LIVMARLI’s new tablet form offers patients weighing 22 kg or more a convenient, one-tablet-per-dose option, complementing the existing 9.5 mg/ml oral solution
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Stalevo Tablets
Inspection included drug device combinations covering our recent filing in nasal sprays domain
N17350 is the company’s first-in-class tumor-directed therapeutic, designed to harness the ELANE pathway
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
A nationwide network of over 1,000 accredited clinical trial sites will be created to accelerate drug development timelines and enhance research credibility
The base Gland business posted ?11,790 million in revenue, up 16% YoY
Growth across inorganic & organic chemicals, fertilisers, pharmaceuticals, cosmetics, soaps and detergents
HD causes cognitive, behavioral, and physical challenges, including involuntary movements known as HD chorea, which can disrupt daily life
Jagsonpal Pharmaceuticals has reported total income of Rs. 75.92 crore during the period ended December 31, 2025
Subscribe To Our Newsletter & Stay Updated
